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GPCR signalingThe regulator of G protein signaling 2 (RGS2) is a potent negative regulator of Gq protein signals including the
angiotensin II (AngII)/AngII receptor signal, which plays a critical role in the progression of ﬁbrosis. However,
the role of RGS2 on the progression of kidney ﬁbrosis has not been assessed. Here, we investigated the role of
RGS2 in kidney ﬁbrosis induced by unilateral ureteral obstruction (UUO) in mice. UUO resulted in increased ex-
pression of RGS2 mRNA and protein in the kidney along with increases of AngII and its type 1 receptor (AT1R)
signaling and ﬁbrosis. Furthermore, UUO increased the levels of F4/80, Ly6G, myeloperoxidase, and CXCR4 in
the kidneys. RGS2 deﬁciency signiﬁcantly enhanced these changes in the kidney. RGS2 deletion in the bone
marrow-derived cells by transplanting the bone marrow of RGS2 knock-out mice into wild type mice enhanced
UUO-induced kidney ﬁbrosis. Overexpression of RGS2 in HEK293 cells, a human embryonic kidney cell line, and
RAW264.7 cells, a monocyte/macrophage line, inhibited the AngII-induced activation of ERK and increase of
CXCR4 expression. These ﬁndings provide the ﬁrst evidence that RGS2 negatively regulates the progression of
kidney ﬁbrosis following UUO, likely by suppressing ﬁbrogenic and inﬂammatory responses through the inhibi-
tion of AngII/AT1R signaling.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Fibrosis is a common feature of chronic kidney diseases. The
progression of ﬁbrosis is associated with excessive production of extra-
cellularmatrix proteins and inﬂammatory cell accumulation, and conse-
quently leads to the loss of function of organs [1,2]. Therefore, it has
been suggested that regulation of kidney ﬁbrogenesis is an important
consideration in the treatment of chronic kidney diseases. To date,
many of the underlying cellular and molecular mechanisms for kidney
ﬁbrosis have been unveiled, but effective therapeutic strategies for
preventing and treating kidney ﬁbrosis have not yet been developed.
Angiotensin II (AngII)/AngII receptors are known as amajor factor in
mediating the progression of various diseases inmany organs [3]. In the
kidney, AngII is a representative ﬁbrogenic factor in the progression of
ﬁbrosis, and AngII and its receptors are ubiquitously expressed in kid-
ney cells [4]. Owing to these characteristics of AngII, renin inhibitors,
AngII-converting enzyme inhibitors, and antagonists of AngII receptors
have been broadly used to treat chronic kidney diseases clinically [5].
AngII type 1 receptor (AT1R) is a G protein-coupled receptor (GPCR),yungpook National University
700-422, Republic of Korea.which is a major therapeutic target of approximately half of the drugs
currently being developed [6,7]. Ligands such as AngII bind to a GPCR,
and that induces the exchange of GDP into GTP in the Gα subunit of G
protein and dissociation of the Gβγ subunit, leading to the activation
of numerous downstream signaling molecules, such as mitogen-
activated protein kinases [6,8].
Regulator of G protein signaling (RGS) proteins comprise more than
30 isoforms in mammalian cells and serve as GTPase-activating pro-
teins, resulting in initiation of GTP hydrolysis and, consequently, termi-
nation of G protein signaling [6,9,10]. RGS2 selectively inhibits Gαq and
Gαi signaling and their respective downstream signals [11–14]. In the
kidney, RGS2 is distributed in most segments of kidney tubules, includ-
ing the proximal and distal tubules, and collecting ducts [15], and both
kidney-speciﬁc and whole body RGS2 deﬁciency results in increased
blood pressure [16]. These ﬁndings suggest that RGS2 plays a critical
role in the progression of kidney diseases such as ﬁbrosis-related dis-
eases. However, the speciﬁc role of RGS2 in kidney ﬁbrosis has not
been determined.
Therefore, the present study aimed to deﬁne the role of RGS2 in the
progression of kidney ﬁbrosis induced by ureteral obstruction. We
found that RGS2 negatively regulates the progression of ﬁbrosis in the
kidneys, likely by suppressing AngII/AT1R signaling. Our ﬁndings
suggest that RGS2 could be a novel therapeutic target for treatment of
chronic kidney diseases.
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2.1. Animal preparation
RGS2 wild type (RGS2+/+) and deﬁcient (RGS2−/−) mice were
used as described previously [17]. All experiments were conducted
with 8-week-old female mice weighing 20–25 g. The study was ap-
proved by the Institutional Animal Care and Use Committee of
Kyungpook National University. Mice were allowed free access to
water and standard mouse chow. Animals were anesthetized with in-
traperitoneal injection of pentobarbital sodium (60 mg/kg body
weight; Sigma; St. Louis, MO) before surgery. Unilateral ureteral ob-
struction (UUO) was induced as previously described [18]. In brief, kid-
neys were exposed via ﬂank incisions. The right ureters of the mice
were completely obstructed near the renal pelvis by 6–0 nylon and
then the incision was sutured. Sham-operated mice were subjected to
the same surgical procedure except for the ureter ligation. Kidneys
were harvested at 3 and 5 days after UUO. Kidneys were either snap-
frozen in liquid nitrogen for Western blot analysis or perfusion-ﬁxed
in PLP (4% paraformaldehyde, 75 mM L-lysine, 10 mM sodium
periodate; Sigma; St. Louis, MO) for histological studies.2.2. Western blot analysis
Western blot analyses were conducted as previously described [19]
using anti-RGS2 (Novus; Littleton, CO), Gαq (Santa Cruz Biotechnology;
Santa Cruz, CA), AngII (Abcam; Cambridge, UK), AT1R (Santa Cruz
Biotechnology; Santa Cruz, CA), collagen I (Santa Cruz Biotechnology;
Santa Cruz, CA), α-SMA (Sigma; St. Louis, MO), p-ERK (Cell Signaling;
Danvers, MA), t-ERK (Santa Cruz Biotechnology; Santa Cruz, CA), PAI-1
(Santa Cruz Biotechnology; Santa Cruz, CA), MPO (Dako; Glostrup,
Denmark), F4/80 (AbD Serotec; Oxford, UK), Ly6G (ebioscience; San
Diego, CA), CXCR4 (eBioscience; San Diego, CA), TGF-β (Santa Cruz
Biotechnology; Santa Cruz, CA), Fibronectin (Santa Cruz Biotechnology;
Santa Cruz, CA), and GAPDH (Santa Cruz Biotechnology; Santa Cruz,
CA) antibodies. Densities of blots were measured using the ImageJ pro-
gram (NIH; Bethesda, MD).2.3. Immunostaining
Immunohistochemistry staining was performed as described previ-
ously [20] using anti-RGS2 (Santa Cruz Biotechnology; Santa Cruz,
CA), AngII (Abcam; Cambridge, UK), AT1R, Gαq (Santa Cruz Biotechnol-
ogy; Santa Cruz, CA), andα-SMA antibodies. To determine non-speciﬁc
responses, goat serum was used instead of those primary antibodies.
Images were captured in the cortex using a Leica DM2500 microscope
(Leica; Germany). α-SMA-positive areas were counted using i-
Solution software (iMT technology; Vancouver, Canada) and averaged
in 10 ﬁelds per kidney.2.4. Semi-quantitative reverse transcription polymerase chain reaction
(RT-PCR)
mRNA from the kidney was prepared with TRIzol reagent as previ-
ously described [21]. To perform RT-PCR, cDNA was synthesized using
a Revert AidTM ﬁrst strand cDNA synthesis kit (Fermentas; Vilnius,
Lithuania). RT-PCR was performed using primers RGS2 (5GGCAACGG
CCCCAAGGTCGAGG3 and 5AAGCAGCCACTTGTAGCCTCTTG3) and
GAPDH (5TATGATGACATCAAGAAGGTGG3 and 5CACCACCCTGTTG
CTGTA3) and Hot Star Taq DNA polymerase (Qiagen; Hilden,
Germany). Twenty-three and 18 ampliﬁcation cycles were performed
using PCR machine (CG1-96, Corbett Research, Sydney, Australia) for
RGS2 and GAPDH, respectively. Densities of bands were quantiﬁed
using the ImageJ program (NIH; Bethesda, MD).2.5. Histology
PLP-ﬁxed kidneyswere embedded in parafﬁn and cut into 2-μmsec-
tions. Sections were stained with Masson's trichrome following the
standard protocol [22]. Images of the cortex in the kidney were cap-
tured, and the area of collagen deposition visualized by Masson's
trichrome staining was determined using i-Solution software (iMT
technology; Vancouver, Canada) and averaged in 10 ﬁelds per kidney.
2.6. Preparation of BM chimeric mice
As described previously [23], we generated BM chimera mice by BM
transplantation. In brief, BM was taken from the femurs and tibias of
mice euthanized with an overdose of pentobarbital sodium. BM cells
at a density of 1 × 107 were injected into the tail vein of recipient
mice (8 weeks old) irradiatedwith 8 Gy using a cesium-137 source irra-
diator. BM-transplanted mice were left to reconstitute BM for 8 weeks.
Lethal irradiated mice started to die about 6 days after irradiation when
reconstitution of BM had failed.
2.7. HEK 293 and RAW264.7 cell culture and RGS2 overexpression
HEK 293 (American Type Culture Collection, Manassas, VA) and
RAW264.7 (American Type Culture Collection, Manassas, VA) cells
were cultured in Dulbecco's modiﬁed Eagle mediumwith 10% fetal bo-
vine serum (FBS; Mediatech Inc.; Manassas, VA) and 100 μl/ml of strep-
tomycin/penicillin (S/P; WelGENE Inc.; Daegu, Korea). hRGS2-pEGFP-
C1 plasmid or a mock was transfected to 60–70% conﬂuent HEK 293
and RAW264.7 cells for 6 h in 10% FBS with S/P and then incubated for
24 h before subculture in 12-well culture plates [24]. The cells grown
in 12-well culture plates were treated with 100 nM of AngII (Sigma;
St. Louis, MO) for 30 min. Cells were rinsed with cold phosphate-
buffered saline, lysed, and subjected to Western blot analyses.
2.8. Statistical analysis
Results are expressed as the means ± SEM. Statistical differences
among groups were calculated using Student's t-test. Differences be-
tween groups were considered statistically signiﬁcant at a p-value
b0.05.
3. Results
3.1. UUO increases RGS2 expression in the kidney with increased
AngII/AT1R expression
Since UUO activates the signals of AngII/AngII receptors [4], and
RGS2 is expressed in kidney tubular epithelial cells [15], we ﬁrst evalu-
ated whether UO alters RGS2 expression in the kidney of mice. We
found that UUO signiﬁcantly increased the expression levels of RGS2
mRNA and protein in the kidney in a time-dependent manner (Fig. 1A
and B). In addition, UUO markedly increased the expression of RGS2
in the cytosol andmembrane of tubular epithelial cells and interstitium
in the kidney (Fig. 1C) when compared with sham-operated kidneys.
Negative control did not show any signal (Suppl. 1). These data indicate
that UUO results in an increase in the amount and change of localization
of RGS2 in the kidney.
Next, we determined the localization and amount of Gαq protein in
the kidney after UUO. In the sham-operated kidneys, Gαq was inten-
sively expressed in the luminal side of tubules, whereas in the UUO kid-
neys, Gαq was intensively expressed in the cytosol of tubular epithelial
cells and in the basement membrane of tubules (Fig. 1D) and there was
no change in Gαq expression levels in the kidney (Fig. 1E). Negative
control did not show any signal (Suppl. 1).
Furthermore, we investigated whether UUO changes the levels of
AngII/AT1R expression, a representative Gq-GPCR. UUO dramatically
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Fig. 1. Expression and localization of RGS2 and Gαq proteins in the kidney after unilateral ureteral obstruction (UUO). Mice were subjected to either UUO or a sham operation. Kidneys
were harvested 3 or 5 days after the operation. (A) The level of RGS2mRNAwas evaluated by RT-PCR. Expression of RGS2 (B) andGαq (E) proteinwasmeasured viaWestern blot analysis.
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1735H.-S. Jang et al. / Biochimica et Biophysica Acta 1842 (2014) 1733–1741increased the expression level of AngII in the kidney (Fig. 2A). In the
normal kidney, AngII was strongly expressed in the lumen of tubules
and was weakly expressed in the cytosol of tubular epithelial cells,
whereas in UUO kidneys, AngII was strongly expressed in the cytosol
and basementmembrane of tubular epithelial cells (Fig. 2B). In particu-
lar, the basement membrane expression of AngII was predominant in
the tubules atrophied by UUO (Fig. 2B). Negative control did not show
any signal (Suppl. 1). Similar to the amount and expression pattern of
AngII, UUO resulted in increased expression of AT1R (Fig. 2C) and
changes in the localization of AT1R (Fig. 2D). In the normal kidney,
AT1R was intensively expressed in the luminal side of tubules, similar
to AngII expression (Fig. 2D), whereas in UUO kidneys, AT1R was
strongly expressed in the cytosol and basement membrane of tubular
epithelial cells and in the interstitium (Fig. 2D). Negative control did
not show any signal (Suppl. 1). This increase in basement membrane
expression of AngII and AT1R may reﬂect the enhanced binding of
AngII to AT1R. Therefore, the increase in kidney RGS2 expression after
UUOmay be required to prevent the UUO-induced excessive activation
of AngII/AT1R.
3.2. Deletion of RGS2 accelerates UUO-induced kidney ﬁbrosis
To investigate whether RGS2 plays a role as a negative regulator of
UUO-induced kidney ﬁbrosis, we determined the levels of kidney ﬁbro-
sis after UUO in RGS2 gene-deleted (RGS2−/−) andwild type (RGS2+/+)
mice. UUO dramatically increased collagen deposition in the intersti-
tium, and this increase wasmore severe in the RGS2−/−mouse kidneysthan in the RGS2+/+mouse kidneys (Fig. 3A). Consistentwith the depo-
sition of collagen, UUO increased alpha-smooth muscle actin (α-SMA)
expression in the interstitium, which was greater in the RGS2−/−
mouse kidneys than in the RGS2+/+ mouse kidneys (Fig. 3B). Quantita-
tive analysis of α-SMA and collagen I using Western blotting showed
that RGS2−/−mice showed enhancement of UUO-induced increases in
the amount of α-SMA and collagen I expression (Fig. 3C), indicating
that RGS2 prevents kidney ﬁbrosis.
3.3. Deletion of RGS2 accelerates UUO-induced inﬂammatory responses
The progression of kidney ﬁbrosis is highly associated with inﬂam-
matory responses including inﬁltration of bone marrow-derived cells
(BMDCs) [25] and production of chemokines [11,26]. In addition,
AngII/AT1R increases inﬂammatory responses in UUO-induced kidneys
[27]. Thus, we investigated the involvement of RGS2 on UUO-induced
inﬂammatory responses and TGF-β expression. UUO signiﬁcantly in-
creased the levels of myeloperoxidase (MPO; a marker of neutrophil/
polymorphonuclear leukocytes), F4/80 (a marker of macrophages),
and Ly6G (a marker of neutrophils) in the kidneys (Fig. 4A to D).
These UUO-induced increases were higher in the RGS2−/− mice than
in the RGS2+/+ mice (Fig. 4A to D). Consistent with the level of inﬂam-
mation, the expression of CXCR4was higher in UUO kidneys of RGS2−/−
mice than in those of RGS2+/+mice (Fig. 4A and E). CXCR4 is expressed
in the kidney tubules as well as BMDCs [28,29] and induces the chemo-
taxis of BMDCs into injured tissues [30–32]. Inhibition of CXCR4 pre-
vents tissue ﬁbrosis and inﬂammation in many organs, including the
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1736 H.-S. Jang et al. / Biochimica et Biophysica Acta 1842 (2014) 1733–1741kidney [33,34]. Furthermore, UUO-induced increase of TGF-βwasgreat-
er in the RGS2−/−mice than in the RGS2+/+mice (Fig. 4A and F). These
results indicate that the antiﬁbrotic effect of RGS2 is associated with in-
hibition of the UUO-induced inﬂammatory response.
3.4. Deletion of RGS2 enhances UUO-induced ERK activation, a downstream
effector of AngII/AT1R signaling
Binding of G proteins to their respective receptors activates ERK, a
downstream target molecule of G protein-GPCR signaling [8,35]. There-
fore, to investigate whether UUO-induced RGS2 expression plays a
negative regulatory role in G protein signaling, we determined the
levels of ERK activation in the presence and absence of RGS2. UUO in-
creased AT1R expression in the kidney and RGS2 gene deletion en-
hanced its increases (Fig. 5A and B). In addition, UUO-induced ERK
activation was greater in the RGS2−/−mice than in the RGS2+/+ mice
(Fig. 5A and C), indicating that RGS2 is a negative regulator of G
protein-GPCR signals. Furthermore the expression of PAI-1, which is a
mediator of kidney ﬁbrosis and is regulated by AngII [36], was alsogreater in the kidneys of RGS2−/−mice than in the kidneys of RGS2+/
+ mice (Fig. 5A and D). These data demonstrate that RGS2 is a negative
modulator of AngII/AT1R signaling in UUO-induced kidneys.
3.5. Deletion of RGS2 in BMDCs enhances kidney ﬁbrosis after UUO
Kidney ﬁbrosis is associated with the inﬁltration and subsequent
proliferation and transdifferentiation of BMDCs into the obstructed kid-
ney [25], Furthermore, as reported above, AngII/AT1R expression was
increased in the interstitium after UUO. Therefore, we evaluated the
role of BMDC-speciﬁc RGS2 in kidney ﬁbrosis. In a previous studywe re-
ported that BMDCs, reconstituted by BM transplantation, inﬁltrated into
the UUO-induced kidney and played a major role in contributing to the
increase of interstitial cell population in UUO-induced kidney [25]. To
this end, we generated four groups of bone marrow (BM) chimeric
mice using BM transplantation: group 1was RGS2+/+mice that received
RGS2+/+ BM; group 2 was RGS2+/+ mice that received RGS2−/− BM;
group 3 was RGS2−/− mice that received RGS2+/+ BM; and group 4
was RGS2−/− mice that received RGS2−/− BM. UUO increased the
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1737H.-S. Jang et al. / Biochimica et Biophysica Acta 1842 (2014) 1733–1741expression of ﬁbronectin, α-SMA, and Ly6G in the kidneys of all four
groups of chimeric mice in the following order: group 1 b group 2 =
group 3 b group 4 (Fig. 6). Expression of the ﬁbrogenic cytokine
transforming growth factor-beta (TGF-β) showed a similar pattern
(Fig. 6). These data indicate that the presence or absence of RGS2 in
BMDCs is also important for controlling kidney ﬁbrosis.
3.6. RGS2 overexpression suppresses the AngII-induced ERK activation and
increase of CXCR4 expression
Finally,we testedwhether RGS2overexpression negatively regulates
AngII-induced downstream signaling in embryonic kidney cells (HEK
293 cells) and macrophages (RAW 264.7 cells). First, we determined
whether overexpression of RGS2 in HEK293 cells (Fig. 7A) reduces
AngII-induced ERK activation and CXCR4 production. AngII induced ac-
tivation of ERK, which was signiﬁcantly inhibited by RGS2 overexpres-
sion (Fig. 7B and C). Similarly, RGS2 overexpression signiﬁcantly
inhibited the AngII-induced increase in CXCR4 expression (Fig. 7B and
D). Next, under the same conditions used for HEK293 cell experiments,
we determined whether RGS2 overexpression in RAW264.7 cells
(Fig. 7E) also negatively regulates AngII-induced ERK activation and
CXCR4 expression. Indeed, RGS2 overexpression in RAW264.7 cells
also blocked the AngII-induced ERK activation and increase of CXCR4
expression (Fig. 7F to H). These results indicate that RGS2 inhibits
AngII/AT1R signaling in both kidney tubular epithelial cells and macro-
phages, supporting the results of the animal experiments.
4. Discussion
AngII/AT1R is generally perceived as an important ﬁbrogenic mole-
cule for the progression of kidney ﬁbrosis [5]. In the present study,UUO signiﬁcantly increased AngII and AT1R expression in the kidney,
and simultaneously increased RGS2 expression. These results suggest
that an increase in RGS2 acts as an inhibitor of AngII/AT1R signaling to
protect the kidneys from injury. In fact, we found that RGS2 gene dele-
tion resulted in exacerbatedUUO-induced kidney ﬁbrosis and enhanced
AngII/AT1R signaling.
RGS2 is a known negative regulator of G protein signaling, which in
turn controls the downstream signal of AngII in in vitro systems [13].
Recently, Gurley and colleagues reported that kidney-speciﬁc RGS2 de-
letion induced hypertension [16], indicating that kidney RGS2 could be
involved in the regulation of AngII/AT1R signaling-related kidney dis-
eases. Overexpression of Gαq protein in HEK293 cells triggers the
sustained activation of several GPCRs including AT1R [37,38]. In the kid-
ney, Gq transgenic mice that constitutively expressed an active Gαq
subunit in podocytes showed albuminuria and enhanced susceptibility
to exposure of puromycin aminonucleoside [39], suggesting that failure
to inactivate Gq-coupled receptor signaling contributes to the develop-
ment of kidney injury. These studies have demonstrated that G protein
signaling is tightly associated with pathogenesis in the kidney.
Inﬂammation is considered to contribute to the initiation and pro-
gression of kidney ﬁbrosis. Recently, we reported that the inﬁltration
and subsequent differentiation of BMDCs to ﬁbroblasts are important
events in the progression of kidney ﬁbrosis after UUO [25], in addition
to ischemia and reperfusion injury [40]. In addition, the inhibition of
recruitment of BMDCs into the kidney, particularly macrophages,
prevented the progression of kidney ﬁbrosis [25]. In our present study,
ablation of the RGS2 gene resulted in enhanced inﬂammation in the kid-
ney after UUO, suggesting a role of RGS2 inmodulation of the inﬂamma-
tory response during the progression of kidney ﬁbrosis. In the present
study, UUO-induced increase of TGF-β expression was greater in
the RGS2-KO than in the RGS2-WT mice. TGF-β is a representative
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blocking AngII signals with angiotensin converting enzyme inhibitors
and AT1R blockers [41–43]. It indicates that RGS2 may suppress UUO-
induced activation of TGF-β signaling pathways.
RGS proteins have been shown to affect the regulation of chemokine
receptors including CXCR4 [44–46]. The SDF-1/CXCR4 axis is required
for engraftment of bone marrow-derived stem/progenitor cells into
the tissue and contributes to the progression of tissue ﬁbrosis [33,34,
47]. CXCR4 is expressed in the parenchymal cells of several organs, in-
cluding the kidney, as well as in BMDCs [28,29]. AngII increases CXCR4
in HEK293 and RAW264.7 cells and consequently induces chemotaxis
[8,31]. In the present study, increases of CXCR4 expression aswell as in-
ﬂammatory cell inﬁltrationwere greater in the UUOkidneys of RGS2−/−
mice than in those of RGS2+/+ mice. In addition, RGS2 deletion in
BMDCs resulted in increased inﬂammation and kidney ﬁbrosis. These
results suggest that RGS2 regulates the recruitment of BM-derivedinﬂammatory cells into a kidneywith UUOby down-regulating the pro-
duction of chemokines such as CXCR4 in both resident kidney cells and
BMDCs. It has been suggested that RGS proteins, including RGS2, are in-
volved in the regulation of chemokines expressed in both resident kid-
ney cells and BMDCs [28–30,32]. In fact, RGS2 overexpression inhibited
the AngII-induced increases of CXCR4 expression in HEK cells and
RAW264.7 cells, supporting its role in the regulation of CXCR4. Although
no signiﬁcant differences were observed in the packed cell volume and
survival rate between RGS2 WT and RGS2 KO recipient mice after BM
transplantation, we could not exclude the possibility that the difference
of inﬂammatory cell inﬁltration into the kidney after UUO, between
RGS2 WT- and RGS2 KO-BM chimeric mice, could be due to the rate of
engraftment. Therefore, further studies are required to deﬁne this.
Accumulated data have demonstrated that G proteins such as AngII
can activate ERK, whereas antagonism of AT1R prevents ERK activation
[35,48,49].Wolf et al. reported that antagonismof AT1R reduced kidney
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1740 H.-S. Jang et al. / Biochimica et Biophysica Acta 1842 (2014) 1733–1741ﬁbrosis along with suppression of ERK activation [49]. In our present
study, RGS2 deletion in vivo enhanced the UUO-induced activation of
ERK, whereas RGS2 overexpression in vitro suppressed the AngII-
induced activation of ERK, indicating that RGS2 negatively regulates
AngII/AT1R signaling. Recent data by Zhang and colleagues showed
that RGS2 inhibits AngII-induced collagen synthesis and cell prolifera-
tion in cardiac ﬁbroblasts in vitro, suggesting an anti-ﬁbrotic role of
RGS2 [50].
Collectively, our ﬁndings reveal, for the ﬁrst time, that RGS2 sup-
presses kidney ﬁbrosis through the suppression of AngII/AT1R signaling,
which includes ERK activation, chemokine production, proﬁbrotic cyto-
kine, and inﬂammatory responses. Therefore, RGS2 appears to be an at-
tractive target for prevention of ﬁbrotic progression in the kidney.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2014.06.022.
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